LENTIVIRAL-MEDIATED GENE THERAPY FOR PATIENTS WITH FANCONI ANEMIA [GROUP A]: UPDATED RESULTS FROM GLOBAL RP-L102 CLINICAL TRIALS

被引:0
|
作者
Sevilla, Julian [1 ,2 ]
Booth, Claire [3 ]
Czechowicz, Agnieszka [4 ,5 ]
Agarwal, Rajni [4 ,5 ]
Zubicaray, Josune [1 ]
Rio, Paula [2 ,6 ,7 ]
Chetty, Kritika [3 ]
O'Toole, Grainne [3 ]
Xu-Bayford, Jinhua [3 ]
Ancliff, Philip [3 ]
Sebastian, Elena [1 ]
Choi, Grace [8 ]
Zeini, Miriam [8 ]
Nicoletti, Eileen [8 ]
Eide, Cindy [9 ]
Wagner, John [9 ]
Rao, Gayatri [8 ]
Thrasher, Adrian [3 ]
Schwartz, Jonathan [8 ]
Roncarolo, Maria Grazia [4 ,5 ]
Bueren, Juan [2 ,6 ,7 ]
机构
[1] Hosp Infantil Univ Nino Jesus HIUNJ, Fdn Invest Biomed, Madrid, Spain
[2] Ctr Invest Biomed Red Enfermedades Raras CIBERER, Madrid, Spain
[3] UCL Great Ormond St Inst Child Hlth, London, England
[4] Stanford Univ, Sch Med, Stanford, CA USA
[5] Lucile Packard Childrens Hosp, Palo Alto, CA USA
[6] Ctr Invest Energet Medioambientales & Tecnolog CI, Madrid, Spain
[7] Inst Invest Sanitaria Fdn Jimenez Diaz IIS FJD, Madrid, Spain
[8] Rocket Pharmaceut Inc, Cranbury, NJ USA
[9] Univ Minnesota, Minneapolis, MN USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
P182
引用
收藏
页码:276 / 277
页数:2
相关论文
共 50 条
  • [41] Changing the Treatment Paradigm for Pyruvate Kinase Deficiency with Lentiviral Mediated Gene Therapy: Interim Results from an Ongoing Global Phase 1 Study
    Shah, A. J.
    Lopez Lorenzo, J. L.
    Navarro, S.
    Sevilla, J.
    Llanos, L.
    de Camino Gaisse, B. Perez
    Sanchez, S.
    Glader, B.
    Chien, M.
    Quintana Bustamante, O.
    Zeini, M.
    Choi, G.
    Nicoletti, E.
    Rao, G. R.
    Roncarolo, M. G.
    Bueren, J. A.
    Schwartz, J. D.
    Segovia, J. C.
    MOLECULAR THERAPY, 2022, 30 (04) : 170 - 170
  • [42] A Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results
    Kohn, Donald
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Booth, Claire
    Thrasher, Adrian
    Bueren, Juan
    Schwartz, Jonathan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2021, 41 (SUPPL 1) : S126 - S126
  • [43] A phase 1/2 study of lentiviral-mediated ex-vivo gene therapy for pediatric patients with severe leukocyte adhesion deficiency-I (LAD-I): Interim results
    Booth, C.
    Kohn, D. B.
    Sevilla, J.
    Rao, G. R.
    Almarza, E.
    Terrazas, D.
    Nicoletti, E.
    Fernandes, A.
    Kuo, C.
    De Oliveira, S.
    Moore, T. B.
    Law, K. M.
    Beard, B. C.
    Choi, G.
    Zeini, M.
    Mesa-Nunez, C.
    Thrasher, A. J.
    Bueren, J.
    Schwartz, J.
    HUMAN GENE THERAPY, 2021, 32 (19-20) : A5 - A5
  • [44] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results
    Kohn, Donald B.
    Booth, Claire
    Sevilla, Julian
    Rao, Gayathri R.
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    Oliveira, Satirode
    Moore, Theodore B.
    Law, Kenneth M.
    Beard, Brian C.
    Choi, Grace
    Zeini, Miriam
    Mesa-Nunez, Cristina
    Thrasher, Adrian J.
    Bueren, Juan A.
    Schwartz, Jonathan D.
    BLOOD, 2021, 138
  • [45] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Interim Results
    Kohn, Donald B.
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliviera, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Booth, Claire
    Thrasher, Adrian
    Bueren, Juan
    Schwartz, Jonathan
    MOLECULAR THERAPY, 2021, 29 (04) : 19 - 20
  • [46] A Phase 1/2 Study of Lentiviral-mediated Ex-vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Initial Results from the First Treated Patient
    Kohn, Donald
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa, Christina
    Bueren, Juan
    Schwartz, Jonathan
    JOURNAL OF CLINICAL IMMUNOLOGY, 2020, 40 (SUPPL 1) : S103 - S103
  • [47] A Phase 1/2 Study of Lentiviral-Mediated Ex-Vivo Gene Therapy for Pediatric Patients with Severe Leukocyte Adhesion Deficiency-I (LAD-I): Initial Results from the First Treated Patient
    Kohn, Donald
    Rao, Gayatri
    Almarza, Elena
    Terrazas, Dayna
    Nicoletti, Eileen
    Fernandes, Augustine
    Kuo, Caroline
    De Oliveira, Satiro
    Moore, Theodore
    Law, Ken
    Beard, Brian
    Sevilla, Julian
    Mesa-Nunez, Cristina
    Bueren, Juan
    Schwartz, Jonathan
    MOLECULAR THERAPY, 2020, 28 (04) : 56 - 57
  • [48] Lentiviral-Mediated Gene Therapy Results in Sustained Expression of β-Glucuronidase for up to 12 Months in the Gusmps/mps and up to 18 Months in the Gustm(L175F)Sly Mouse Models of Mucopolysaccharidosis Type VII
    Derrick-Roberts, Ainslie L. K.
    Pyragius, Carmen E.
    Kaidonis, Xenia M.
    Jackson, Matilda R.
    Anson, Donald S.
    Byers, Sharon
    HUMAN GENE THERAPY, 2014, 25 (09) : 798 - 810
  • [49] Haematopoietic gene therapy of non-conditioned patients with Fanconi anaemia-A: results from open-label phase 1/2 (FANCOLEN-1) and long-term clinical trials
    Rio, Paula
    Zubicaray, Josune
    Navarro, Susana
    Galvez, Eva
    Sanchez-Dominguez, Rebeca
    Nicoletti, Eileen
    Sebastian, Elena
    Rothe, Michael
    Pujol, Roser
    Bogliolo, Massimo
    John-Neek, Philipp
    Bastone, Antonella Lucia
    Schambach, Axel
    Wang, Wei
    Schmidt, Manfred
    Larcher, Lise
    Segovia, Jose C.
    Yanez, Rosa M.
    Alberquilla, Omaira
    Diez, Begona
    Fernandez-Garcia, Maria
    Garcia-Garcia, Laura
    Ramirez, Manuel
    Galy, Anne
    Lefrere, Francois
    Cavazzana, Marina
    Leblanc, Thierry
    de Andoin, Nagore Garcia
    Lopez-Almaraz, Ricardo
    Catala, Albert
    Barquinero, Jordi
    Rodriguez-Perales, Sandra
    Rao, Gayatri
    Surralles, Jordi
    Soulier, Jean
    Diaz-de-Heredia, Cristina
    Schwartz, Jonathan D.
    Sevilla, Julian
    Bueren, Juan A.
    LANCET, 2024, 404 (10471): : 2584 - 2592
  • [50] Lovo-cel (bb1111) Gene Therapy for Sickle Cell Disease: Updated Clinical Results and Investigations into Two Cases of Anemia from Group C of the Phase 1/2 HGB-206 Study
    Walters, Mark C.
    Thompson, Alexis A.
    Kwiatkowski, Janet L.
    Parikh, Suhag
    Mapara, Markus Y.
    Rifkin-Zenenberg, Stacey
    Aygun, Banu
    Kasow, Kimberly A.
    Miller, Alex
    Zhang, Lixin
    Chawla, Anjulika
    Macari, Elizabeth R.
    Pierciey, Francis J.
    Tisdale, John F.
    Kanter, Julie
    BLOOD, 2022, 140